Miragen Therapeutics (NASDAQ: MGEN) Acquire Viridian Therapeutics
Hasnain Khan
October 28, 2020
Miragen Therapeutics, Inc. (NASDAQ: MGEN) shares traded up 125.04% during the pre-market trading session after the biotechnology company has announced that it has acquired Viridian